Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus (NCT07187479)
Randomized, Open Label Study to Examine the Outcomes of Physiologic Insulin Resensitization in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).
Who can join: Review the eligibility criteria below.
Location: Arizona Kidney Disease and Hypertension Center — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
- Physiologic Insulin Resensitization (PIR) (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Arizona Kidney Disease and Hypertension Center — Phoenix, Arizona
- Innovative Diabetic Center — Scottsdale, Arizona
📞 Contact the Study Coordinator
Phone: (205) 612-4763
Email: rmarchase@gmail.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Kidney Disease (Stages 4 and 5)
- Kidney RISE: Randomized Integrated Supportive CarE Trial — Atlanta, Georgia
- Probiotic and Prebiotic Supplementation in Peritoneal Dialysis Patients — Monterrey, Nuevo León
- Symptom Monitoring With Supported Feedback in Advanced Chronic Kidney Disease — Boston, Massachusetts
Explore by condition: All Chronic Kidney Disease (Stages 4 and 5) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.